Cargando…
LncRNA NKILA was upregulated in diabetic cardiomyopathy with early prediction values
Nuclear factor-κB interacting long non-coding RNA (LncRNA NKILA) is a well-studied tumor suppressor lncRNA in several types of malignancies. The present study reports the involvement of this lncRNA in diabetic cardiomyopathy (DC). A 8-year-follow-up study on 312 diabetic patients without exhibiting...
Autores principales: | Li, Qingyong, Li, Panrong, Su, Jinling, Liu, Suping, Yang, Xiaoman, Yang, Yuejin, Niu, Suocheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601402/ https://www.ncbi.nlm.nih.gov/pubmed/31316617 http://dx.doi.org/10.3892/etm.2019.7671 |
Ejemplares similares
-
lncRNA‐NKILA/NF‐κB feedback loop modulates laryngeal cancer cell proliferation, invasion, and radioresistance
por: Yang, Tao, et al.
Publicado: (2018) -
Influence of LncRNA NKILA on Bloodstream Infection of Hypervirulent Klebsiella pneumoniae and Its Ability to Induce Delayed Neutrophil Apoptosis
por: Li, Yang, et al.
Publicado: (2021) -
LncRNA NKILA integrates RXFP1/AKT and NF‐κB signalling to regulate osteogenesis of mesenchymal stem cells
por: Zhang, Ying, et al.
Publicado: (2019) -
LncRNA NKILA Promotes Epithelial-Mesenchymal Transition of Liver Cancer Cells by Targeting miR-485-5p
por: Wang, Yuxu, et al.
Publicado: (2021) -
Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
por: Zhang, Min-Yue, et al.
Publicado: (2022)